Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...

Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...

Many of us think we know the key causes and symptoms of lung cancer. However, there are still some misconceptions about the ...

Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 Overlooked Growth Stocks to Buy Now. Zai Lab Limited (NASDAQ:ZLAB) is one of ...

The incidence and mortality rate of esophageal cancer in China fell by around 4.5 percent annually, according to the figures ...

Sarasota Memorial Health Care System (SMH) reported that 75% of lung cancers diagnosed through an innovative early detection program at SMH's Brian D. Jellison Cancer Institute in 2025 were found at ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

An investigational targeted therapy doubled survival compared with standard chemotherapy for pretreated individuals with ...

Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...

Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and survival data well above ...

The Scottish Medicines Consortium has approved osimertinib for adults with unresectable stage III EGFR-mutant NSCLC whose disease has not progressed after platinum-based chemoradiation.

Lung cancer is the deadliest cancer—but early screening can save lives. A survivor’s story and expert insight show why ...